SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-17-000659
Filing Date
2017-02-14
Accepted
2017-02-14 08:02:07
Documents
4

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROSPECTUS SUPPLEMENT a2230897z424b5.htm 424B5 435673
2 G184809.JPG g184809.jpg GRAPHIC 7370
3 G717681.JPG g717681.jpg GRAPHIC 27643
4 G418586.JPG g418586.jpg GRAPHIC 10977
  Complete submission text file 0001047469-17-000659.txt   500958
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-207004 | Film No.: 17602520
SIC: 2834 Pharmaceutical Preparations

Mailing Address 608 FIFTH AVENUE NEW YORK NY 10020
Business Address 608 FIFTH AVENUE NEW YORK NY 10020 (212)307 1122
Novartis Capital CORP (Filer) CIK: 0001443411 (see all company filings)

IRS No.: 263086456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-207004-02 | Film No.: 17602521
SIC: 2834 Pharmaceutical Preparations